The Partners Pediatric Multiple Sclerosis Center at Massachusetts General Hospital annually offers several fellowship opportunities:
1. Clinical fellowship program: Combined Harvard Pediatric Multiple Sclerosis and related disorders Fellowship
Fellows rotate through the Partners Pediatric MS Center at the Massachusetts General Hospital for 1-2 years (With Tanuja Chitnis MD), with additional rotations at Children’s Hospital Boston (with Mark Gorman MD) and the adult Partners MS Center Brigham and Women’s Hospital (with Tanuja Chitnis MD). Fellows will learn about pediatric MS, NMO and related demyelinating disorders (DD) and will build a knowledge base regarding MS, NMO and DD clinical care. Through exposure to adult MS patients they will understand the long-term consequences of MS, including pediatric-onset MS. In addition, fellows will be exposed to cases of autoimmune encephalopathy, opsoclonus-myoclonus and other neuroimmunological disorders. Fellows will participate in direct supervised MS patient-care and multidisciplinary care including a child psychiatrist, neuropsychologist, family counselor and nurse. Fellows will also participate in a research project tailored to their interests, through resources available within the program including a clinical database, ongoing neuroimaging and neuroimmunology studies, clinical trials and access to a national pediatric demyelinating diseases database.
This fellowship is GME accredited by the Partners Program.
Requirements: M.D. degree and completion of a U.S. or Canadian residency program in pediatric neurology or neurology.
Program directors: Tanuja Chitnis M.D. and Mark Gorman
We are currently accepting applications for start date of July 2016. Applications are due by March 1, 2015.
Please prepare your CV, a cover letter describing your interests and goals, along with two letters of recommendation, and send (electronically) directly from the preparer to: Taylor Saraceno at email@example.com for more information.
Past Clinical Fellows:
Mark P. Gorman MD, 2007-2009
Current position: Director, Pediatric Neuroimmunology Clinic, Children Hospital, Boston
· Gorman MP, Healy BC, Polgar-Turcsanyi M, Chitnis T. Increased relapse rate in pediatric-onset compared with adult-onset multiple sclerosis. Arch Neurol. 2009 Jan;66(1):54-9.
· Gorman MP, Tillema JM, Berger AM, Guttmann CR, Chitnis T. Daclizumab use in patients with pediatric multiple sclerosis. Archives of Neurology. 2012 Jan;69(1):78-81. PMCID: PMC22232346
Leslie Benson MD, 2011-2013
Current position: Staff neurologist, Pediatric Neuroimmunology Clinic, Children Hospital, Boston
· Benson LA, Healy BC, Gorman MP, Baruch NF, Ghoulipour T, Musallam A, Chitnis T. Elevated relapse rates in pediatric compared to adult MS persist for at least 6 years. Mult Scler Relat Disord. 2013 June. In press.
2. Clinical Research fellowship program:
Clinical research fellows are offered a rich research environment with exposure to ongoing clinical research in diagnosis, diseases course, response to treatment, clinical trials, neuroimmunology and neuroimaging in pediatric MS, NMO and related demyelinating diseases. The research project depends on current study needs and may be tailored to the fellow’s interests and skills. Access to a comprehensive local and national database on pediatric demyelinating diseases may be utilized. Observation of clinical care may be incorporated into this fellowship.
External sources of funding are an asset.
Requirements: An MD or Ph.D. Prior experience in neuroimmunology, immunology, and neuroscience research are assets.
Program director: Tanuja Chitnis M.D.
We are currently accepting applications for July 2015.
Please prepare your CV, a cover letter describing your interests and goals, along with two letters of recommendation, and send (electronically) directly from the preparer to: Taylor Saraceno at firstname.lastname@example.org
Past Clinical Research Fellows:
Cristina Fernandez-Carbonell MD, 2012-2013
Current position: Clinical fellowship in pediatric MS, Hospital for Sick Children, Toronto, CA
Fellowship Project: Clinical and MRI phenotype of myelin-antibody positive children with demyelinating disease.
· Inflammatory demyelinating disorders in children: An update. Minerva Pediatrica 2013 Jun;65(3):307-23.
David Vargas-Lowy MD, 2008-2012
Current position: Pediatric Neurology resident, SUNY-Buffalo, NY
Fellowship Project: T cell responses to myelin peptides in children with MS
· Vargas-Lowy D, Kivisaak P, Gandhi R, Radassi K, Gorman MP, Khoury SJ, Chitnis T. Increased Th17 response to myelin peptides in pediatric multiple sclerosis. Clin Immunol. 2013 Mar;146(3):176-84. PMCID: PMC23352968
· Vargas-Lowy D., Chitnis T. Pathogenesis of Pediatric Multiple Sclerosis (2012) (review). In Journal of Child Neurology. In press.
Mellekate Vishwas MD, 2008-2009
Current position: Pediatric Neurology resident, Wake Forest, Salem, NC
Fellowship project: Diffusion tensor imaging in pediatric MS, clinically isolated syndromes and ADEM
· Vishwas MS, Chitnis T, Pienaar R, Healy BC, Grant PE. Tract-based analysis of callosal, projection, and association pathways in pediatric patients with multiple sclerosis: a preliminary study. AJNR Am J Neuroradiol. 2010 Jan;31(1):121-128.
· Vishwas MS, Healy BC, Pienaar R, Gorman M, Grant PE, Chitnis T. Diffusion Tensor Analysis of Pediatric Multiple Sclerosis and Clinically Isolated Syndromes. AJNR Am J Neuroradiol. 2012 Aug 2.